Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams

J Pediatr. 2017 Jul:186:192-195.e1. doi: 10.1016/j.jpeds.2017.03.031. Epub 2017 Apr 21.

Abstract

Superficial fungal infections are among the most commonly managed skin problems by general practitioners. Although evidence shows combination antifungal/corticosteroid topicals are more expensive and less effective than single-agent antifungals, practitioners continue to prescribe combination agents. We examined current prescription trends of 2 combination antifungal/corticosteroid medications, Lotrisone and Mycolog-II.

Keywords: betamethasone dipropionate; clotrimazole; diaper dermatitis; nystatin; triamcinolone acetonide.

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Betamethasone / therapeutic use*
  • Child
  • Child, Preschool
  • Clotrimazole / therapeutic use*
  • Dermatomycoses / drug therapy*
  • Drug Combinations
  • Glucocorticoids / therapeutic use*
  • Gramicidin / therapeutic use*
  • Humans
  • Infant
  • Infant, Newborn
  • Neomycin / therapeutic use*
  • Nystatin / therapeutic use*
  • Practice Patterns, Physicians'
  • Triamcinolone Acetonide / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Antifungal Agents
  • Drug Combinations
  • Glucocorticoids
  • Gramicidin, Neomycin Sulfate, Nystatin, Triamcinolone Acetonide Drug Combination
  • Lotrisone
  • Nystatin
  • Gramicidin
  • Betamethasone
  • Triamcinolone Acetonide
  • Clotrimazole
  • Neomycin